News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MISRA TUSHAR
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| MISRA TUSHAR (SVP, Chief Manuf. Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 1,908 shares
@ $1.18, valued at
$2.3k
Exercised 6,250 restricted stock units
@ $0 |
|
| 01/18/2023 |
4
| MISRA TUSHAR (SVP, CMO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 458 shares
@ $5.74, valued at
$2.6k
Granted 127,500 options to buy
@ $6.06, valued at
$772.7k
Granted 28,333 restricted stock units
@ $0
Exercised 1,459 restricted stock units
@ $0 |
|
| 08/18/2022 |
4
| MISRA TUSHAR (Chief Manufacturing Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 1,879 shares
@ $7.1, valued at
$13.3k
Exercised 6,250 restricted stock units
@ $0 |
|
| 01/19/2022 |
4
| MISRA TUSHAR (Chief Manufacturing Officer) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 26,250 options to buy
@ $6.28, valued at
$164.9k
Granted 5,833 restricted stock units
@ $0 |
|
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|